Abstract
The intracorporeal injection of papaverine (ICP) is now a well recognized therapeutic option in the management of impotence. The current treatment of advanced prostatic carcinoma causes erectile failure. Although intracorporeal papaverine can induce erections in these men, libido is also reduced so that the role of ICP is limited to those men complying with the wishes of a highly motivated partner.
| Original language | English |
|---|---|
| Pages (from-to) | 161 |
| Number of pages | 1 |
| Journal | Journal of the Royal Society of Medicine |
| Volume | 83 |
| Issue number | 3 |
| Publication status | Published - 1990 |
| Externally published | Yes |